pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 371 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
freneslerbart + mevonlerbart
Cat Allergy
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Marketed
garadacimab
Andembry (garadacimab [INN])
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
CSL Behring LLC
0 catalysts
pre_registration
gefurulimab
Myasthenia Gravis
Alexion Pharmaceuticals Inc
0 catalysts
Marketed
← prev
page 10 of 13
next →
131
Pain89
Neurology1
golimumab
Simponi (golimumab)
Ankylosing Spondylitis (Bekhterev's Disease)
Janssen Biotech Inc
0 catalysts
pre_registration
golimumab biosimilar
Ankylosing Spondylitis (Bekhterev's Disease)
Bio-Thera Solutions Ltd
0 catalysts
Marketed
grass pollen [cocksfoot (Dactylis glomerata) + sweet vernal (Anthoxanthum odoratum) + rye (Lolium perenne) + meadow (Poa pratensis) + timothy (Phleum pratense)] allergen extract
Oralair
Grass Pollen Allergy
Greer Laboratories Inc
0 catalysts
Marketed
halcinonide
Halcinonide (halcinonide)
Atopic Dermatitis (Atopic Eczema)
Encube Ethicals Inc
0 catalysts
Marketed
halobetasol propionate
Halobetasol Propionate (halobetasol propionate)
Psoriasis
G&W Laboratories Inc
0 catalysts
Marketed
hydrocortisone butyrate
Locoid (hydrocortisone butyrate)
Atopic Dermatitis (Atopic Eczema)
Bausch Health Americas Inc
0 catalysts
Marketed
hydrocortisone valerate
Hydrocortisone Valerate (hydrocortisone valerate)
Atopic Dermatitis (Atopic Eczema)
Cosette Pharmaceuticals Inc
0 catalysts
Marketed
hydroxychloroquine
Hydroxychloroquine Sulfate (hydroxychloroquine [INN])
Malaria
Creekwood Pharmaceutical Inc
0 catalysts
Marketed
hymenoptera venom allergen extract
White Faced Hornet Hymenoptera Venom Multidose
Allergies
Jubilant HollisterStier LLC
0 catalysts
Phase 3
hypericin sodium
Cutaneous T-Cell Lymphoma
$SNGXSOLIGENIX, INC.
0 catalysts
Phase 3
ianalumab
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
Tumor necrosis factor receptor superfamily member 13C
$NVSNOVARTIS AG
0 catalysts
Marketed
ibrutinib
Imbruvica (ibrutinib)
Follicular Lymphoma
Tyrosine-protein kinase BTK
$ABBVAbbVie Inc.
0 catalysts
Marketed
icatibant acetate
Firazyr (icatibant acetate)
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Takeda Pharmaceuticals USA Inc
0 catalysts
Phase 2
ifetroban
Dyscorban (ifetroban)
Duchenne Muscular Dystrophy
$CPIXCUMBERLAND PHARMACEUTICALS INC
0 catalysts
Phase 2
ignaseclant
Myasthenia Gravis
NMD Pharma AS
0 catalysts
Phase 3
imeroprubart
Rheumatoid Arthritis
$IMVTImmunovant, Inc.
0 catalysts
pre_registration
imlifidase
Idefirix (imlifidase)
Kidney Transplant Rejection
Hansa Biopharma AB
0 catalysts
pre_registration
imsidolimab
Generalized Pustular Psoriasis (GPP)
IL36 receptor
$VNDAVanda Pharmaceuticals Inc.
0 catalysts
Marketed
indomethacin sodium
Indomethacin Sodium (indomethacin sodium)
Patent Ductus Arteriosus
Hikma Pharmaceuticals USA Inc
0 catalysts
Marketed
inebilizumab
Uplizna (inebilizumab)
Immunoglobulin G4-Related Disease (IgG4-RD)
Horizon Therapeutics USA Inc
0 catalysts
Marketed
infliximab
Remicade (infliximab)
Plaque Psoriasis (Psoriasis Vulgaris)
Janssen Biotech Inc
0 catalysts
Marketed
iptacopan hydrochloride
Fabhalta (iptacopan hydrochloride)
Myasthenia Gravis
Complement factor B
$NVSNOVARTIS AG
0 catalysts
Marketed
ixekizumab
Taltz (ixekizumab)
Plaque Psoriasis (Psoriasis Vulgaris)
Eli Lilly and Co
0 catalysts
Marketed
lanadelumab
Takhzyro (lanadelumab-flyo)
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Takeda Pharmaceuticals USA Inc
0 catalysts
Marketed
leniolisib
Joenja (leniolisib [INN])
Common Variable Immunodeficiency (CVID)
Pharming Group NV
0 catalysts
Marketed
levofloxacin
Levofloxacin (levofloxacin)
Acute Bacterial Sinusitis
Teva Pharmaceuticals USA Inc
0 catalysts
Phase 3
litifilimab
Cutaneous Lupus Erythematosus
C-type lectin domain family 4 member C
$BIIBBIOGEN INC.
0 catalysts